Stifel Initiates Coverage On Third Harmonic Bio With Buy Rating, Announces Price Target of $23
Stifel Initiates Coverage On Third Harmonic Bio With Buy Rating, Announces Price Target of $23
Stifel開始對Third Harmonic Bio進行覆蓋並給予買入評級，公佈了23美元的目標價。
Stifel analyst Alex Thompson initiates coverage on Third Harmonic Bio (NASDAQ:THRD) with a Buy rating and announces Price Target of $23.
Stifel分析師Alex Thompson開始覆蓋第三諧波生物（納斯達克股票代碼：THRD），併發布買入評級，目標價爲23美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。